Unlock stock picks and a broker-level newsfeed that powers Wall Street.

AstraZeneca Tops Earnings Views And Shares Rise Despite Cancer Miss
AstraZeneca Tops Earnings Views And Shares Rise Despite Cancer Miss · Investor's Business Daily

In This Article:

AstraZeneca stock rose moderately Tuesday despite a mixed first-quarter report and a setback for its experimental prostate cancer treatment.